NCT01089569
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- International Diabetes Center Minneapolis, Minnesota, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,005 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
NCT01076088
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT00885352
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT02298192
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Hamilton, Alabama, United States
- Novo Nordisk Investigational Site Chandler, Arizona, United States
- Novo Nordisk Investigational Site Glendale, Arizona, United States
- Novo Nordisk Investigational Site Glendale, Arizona, United States
NCT00686712
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Charles Drew University of Medicine and Science Los Angeles, California, United States
NCT03159221
- Conditions
- Body Weight, Childhood Obesity, Diabetes Mellitus, +12 more
- Locations
-
- Nemours Children's Specialty Care Jacksonville, Florida, United States
Completed
Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes
NCT00120536
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT00099918
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Novartis Investigative Sites Investigative Centers, Germany
NCT00101803
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT03099928
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified